Extended targeted PRP vs standard PRP: BCVA: loss of 15 or more ETDRS letters
Extended targeted PRP showed no clear difference in BCVA: loss of 15 or more ETDRS letters: compared with standard PRP (low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Extended targeted PRP vs standard PRP BCVA: loss of 15 or more ETDRS letters: · people with diabetic retinopathy Extended targeted PRP showed no clear difference in BCVA: loss of 15 or more ETDRS letters: compared with standard PRP (low certainty). Different lasers and techniques for proliferative diabetic retinopathy (2018) · Cochrane Headline outcomes only | RR 0.94 [0.7, 1.28] | 1 study · 270 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Different lasers and techniques for proliferative diabetic retinopathy 2018 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.